This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Claudio Randal Serafini: Innovator in Ocular Evaluation Technology
Introduction
Claudio Randal Serafini is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of ocular evaluations through his innovative patent. His work focuses on enhancing the efficiency and effectiveness of ocular assessments.
Latest Patents
Claudio Randal Serafini holds a patent for a "Modular platform for ocular evaluations." This screening platform enables comprehensive ocular evaluations and includes a harness designed to fit a patient's head. The platform features electronic components that power an interchangeable module, a central processing unit (CPU) with a graphical processing unit (GPU), and communication capabilities with external devices. The design allows for multiple display outputs and various input devices from both the operator and the patient, making it a versatile tool in ocular assessments. He has 1 patent to his name.
Career Highlights
Claudio is associated with the Icahn School of Medicine at Mount Sinai, where he contributes to advancements in medical technology. His work is pivotal in developing tools that improve patient care and diagnostic accuracy in ocular health.
Collaborations
Claudio collaborates with talented individuals such as Randal Alexander Serafini and Andrew Jinrui Warburton. These partnerships enhance the innovation process and contribute to the development of cutting-edge technologies in the medical field.
Conclusion
Claudio Randal Serafini is a key figure in the realm of ocular evaluation technology, with his innovative patent paving the way for improved patient assessments. His contributions reflect a commitment to advancing medical technology and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
